The rate and risk factors for malignancy in patients with inflammatory bowel disease in Crete: a case control study
The rate of malignancy in IBD patients in Crete is 4.5%. CD disease location and behavior are associated with the development of malignancies. No association with biologics and/or IMMs previous exposure was found. Moreover, initiation of biologics or IMMs after cancer diagnosis was not associated with an adverse impact either on survival or on cancer recurrence.
Authors
- Anǵeliki Theodoropoulou
- K Karmiris
- Kalliopi Foteinogiannopoulou (ORCID: https://orcid.org/0000-0003-0554-5256)
- Eleni Orfanoudaki (ORCID: https://orcid.org/0000-0002-5426-2757)
- Penelope Nikolaou
- I E Koutroubakis
Institutions
- The General Hospital of Heraklion "Venizeleio-Pananio" (GR)
- University Hospital of Heraklion (GR)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2026-01-28
- DOI
- https://doi.org/10.1097/meg.0000000000003093
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00